198 related articles for article (PubMed ID: 35668135)
1. The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.
Thomas GE; Egan G; García-Prat L; Botham A; Voisin V; Patel PS; Hoff FW; Chin J; Nachmias B; Kaufmann KB; Khan DH; Hurren R; Wang X; Gronda M; MacLean N; O'Brien C; Singh RP; Jones CL; Harding SM; Raught B; Arruda A; Minden MD; Bader GD; Hakem R; Kornblau S; Dick JE; Schimmer AD
Nat Cell Biol; 2022 Jun; 24(6):872-884. PubMed ID: 35668135
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
3. Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions.
Seiler K; Humbert M; Minder P; Mashimo I; Schläfli AM; Krauer D; Federzoni EA; Vu B; Moresco JJ; Yates JR; Sadowski MC; Radpour R; Kaufmann T; Sarry JE; Dengjel J; Tschan MP; Torbett BE
Cell Death Dis; 2022 May; 13(5):448. PubMed ID: 35538058
[TBL] [Abstract][Full Text] [Related]
4. MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Catalano G; Zaza A; Banella C; Pelosi E; Castelli G; de Marinis E; Smigliani A; Travaglini S; Ottone T; Divona M; Del Principe MI; Buccisano F; Maurillo L; Ammatuna E; Testa U; Nervi C; Venditti A; Voso MT; Noguera NI
Leukemia; 2023 Aug; 37(8):1600-1610. PubMed ID: 37349598
[TBL] [Abstract][Full Text] [Related]
5. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
Bahr C; von Paleske L; Uslu VV; Remeseiro S; Takayama N; Ng SW; Murison A; Langenfeld K; Petretich M; Scognamiglio R; Zeisberger P; Benk AS; Amit I; Zandstra PW; Lupien M; Dick JE; Trumpp A; Spitz F
Nature; 2018 Jan; 553(7689):515-520. PubMed ID: 29342133
[TBL] [Abstract][Full Text] [Related]
6. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
7. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier.
Santos MA; Faryabi RB; Ergen AV; Day AM; Malhowski A; Canela A; Onozawa M; Lee JE; Callen E; Gutierrez-Martinez P; Chen HT; Wong N; Finkel N; Deshpande A; Sharrow S; Rossi DJ; Ito K; Ge K; Aplan PD; Armstrong SA; Nussenzweig A
Nature; 2014 Oct; 514(7520):107-11. PubMed ID: 25079327
[TBL] [Abstract][Full Text] [Related]
8. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Shlush LI; Zandi S; Mitchell A; Chen WC; Brandwein JM; Gupta V; Kennedy JA; Schimmer AD; Schuh AC; Yee KW; McLeod JL; Doedens M; Medeiros JJ; Marke R; Kim HJ; Lee K; McPherson JD; Hudson TJ; ; Brown AM; Yousif F; Trinh QM; Stein LD; Minden MD; Wang JC; Dick JE
Nature; 2014 Feb; 506(7488):328-33. PubMed ID: 24522528
[TBL] [Abstract][Full Text] [Related]
9. Selective knockdown of hexokinase 2 in rods leads to age-related photoreceptor degeneration and retinal metabolic remodeling.
Zhang R; Shen W; Du J; Gillies MC
Cell Death Dis; 2020 Oct; 11(10):885. PubMed ID: 33082308
[TBL] [Abstract][Full Text] [Related]
10. High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway.
Liu CC; Chou KT; Hsu JW; Lin JH; Hsu TW; Yen DH; Hung SC; Hsu HS
Int J Cancer; 2019 Oct; 145(8):2144-2156. PubMed ID: 30920655
[TBL] [Abstract][Full Text] [Related]
11. Functional DNA repair system analysis in haematopoietic progenitor cells using host cell reactivation.
Thoms KM; Baesecke J; Emmert B; Hermann J; Roedling T; Laspe P; Leibeling D; Truemper L; Emmert S
Scand J Clin Lab Invest; 2007; 67(6):580-8. PubMed ID: 17852814
[TBL] [Abstract][Full Text] [Related]
12. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis.
Yamashita M; Dellorusso PV; Olson OC; Passegué E
Nat Rev Cancer; 2020 Jul; 20(7):365-382. PubMed ID: 32415283
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear chromatin proteins of hematopoietic cells normally and in leukemia in rats].
Shliakhovenko VA; Negreĭ GZ
Vopr Onkol; 1980; 26(3):40-4. PubMed ID: 7368656
[TBL] [Abstract][Full Text] [Related]
15. Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells.
Neary CL; Pastorino JG
J Cell Physiol; 2013 Sep; 228(9):1943-8. PubMed ID: 23629924
[TBL] [Abstract][Full Text] [Related]
16. Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells.
Sheikh T; Gupta P; Gowda P; Patrick S; Sen E
J Biol Chem; 2018 Mar; 293(13):4767-4777. PubMed ID: 29414774
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.
Pan M; Han Y; Basu A; Dai A; Si R; Willson C; Balistrieri A; Scott BT; Makino A
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C732-C740. PubMed ID: 29513568
[TBL] [Abstract][Full Text] [Related]
18. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Wolf A; Agnihotri S; Munoz D; Guha A
Neurobiol Dis; 2011 Oct; 44(1):84-91. PubMed ID: 21726646
[TBL] [Abstract][Full Text] [Related]
19. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
Bustamante MF; Oliveira PG; Garcia-Carbonell R; Croft AP; Smith JM; Serrano RL; Sanchez-Lopez E; Liu X; Kisseleva T; Hay N; Buckley CD; Firestein GS; Murphy AN; Miyamoto S; Guma M
Ann Rheum Dis; 2018 Nov; 77(11):1636-1643. PubMed ID: 30061164
[TBL] [Abstract][Full Text] [Related]
20. Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity.
Lehto M; Huang X; Davis EM; Le Beau MM; Laurila E; Eriksson KF; Bell GI; Groop L
Diabetologia; 1995 Dec; 38(12):1466-74. PubMed ID: 8786021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
